Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.

[1]  D. K. Jagadeesha,et al.  Inhibition of Apoptotic Signaling and Neointimal Hyperplasia by Tempol and Nitric Oxide Synthase following Vascular Injury , 2008, Journal of Vascular Research.

[2]  D. McPherson,et al.  A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery. , 2008, Ultrasound in medicine & biology.

[3]  Shaoling Huang,et al.  Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. , 2008, Journal of pharmaceutical sciences.

[4]  E. Mannarino,et al.  Endothelial Injury and Repair: A Novel Theory for Atherosclerosis , 2008, Angiology.

[5]  Shelton D Caruthers,et al.  Intramural Delivery of Rapamycin With &agr;v&bgr;3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Jonathan A. Kopechek,et al.  Synthesis, Acoustic Stability, and Pharmacologic Activities of Papaverine-Loaded Echogenic Liposomes for Ultrasound Controlled Drug Delivery , 2008, Journal of liposome research.

[7]  S. Wimalawansa.  Nitric oxide: new evidence for novel therapeutic indications. , 2008, Expert opinion on pharmacotherapy.

[8]  Nick D. Tsihlis,et al.  The role of nitric oxide in the pathophysiology of intimal hyperplasia. , 2007, Journal of vascular surgery.

[9]  M. R. Miller,et al.  Recent developments in nitric oxide donor drugs , 2007, British journal of pharmacology.

[10]  C. Holland,et al.  Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. , 2007, Ultrasound in medicine & biology.

[11]  D. McPherson,et al.  Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes , 2007, Journal of drug targeting.

[12]  C. Holland,et al.  Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. , 2007, Thrombosis research.

[13]  M. Gladwin.  Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. , 2006, Advances in experimental medicine and biology.

[14]  T. Evans,et al.  Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.

[15]  J. Fischer,et al.  Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. , 2004, Journal of vascular surgery.

[16]  D. McPherson,et al.  Novel Echogenic Drug-Immunoliposomes for Drug Delivery , 2004, Investigative radiology.

[17]  C. Sibley,et al.  Permeability of the foetal capillary endothelium of the guinea-pig placenta to haem proteins of various molecular sizes , 2004, Cell and Tissue Research.

[18]  I. Sheiban,et al.  Drug-eluting stent: the emerging technique for the prevention of restenosis. , 2002, Minerva cardioangiologica.

[19]  D. McPherson,et al.  Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes: Studies in a New Experimental Model , 2002, Circulation.

[20]  D. McPherson,et al.  A Physiologic Flow Chamber Model to Define Intravascular Ultrasound Enhancement of Fibrin Using Echogenic Liposomes , 2002, Investigative radiology.

[21]  Shaoling Huang,et al.  Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. , 2002, Cellular & molecular biology letters.

[22]  R. D. Rudic,et al.  Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.

[23]  G. Rich,et al.  Inhaled nitric oxide as a selective pulmonary vasodilator in clinical anesthesia. , 1997, AANA journal.

[24]  J. Kuszak,et al.  Development of inherently echogenic liposomes as an ultrasonic contrast agent. , 1996, Journal of pharmaceutical sciences.

[25]  Jesse D. Roberts,et al.  Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. , 1996, Circulation research.

[26]  P. Tsao,et al.  Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. , 1994, Circulation.

[27]  L. Ignarro,et al.  Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.